China’s Zhejiang Beta Pharma, Other Groups To Make Cancer Drug Free
This article was originally published in PharmAsia News
Executive Summary
China’s Zhejiang Beta Pharma has joined other medical groups in offering for free the small molecule-targeted cancer drug Conmana (icotinib), which the drug maker has been selling for the past six months.